tf2024ie

Publisher

Taylor & Francis

Agreement ID tf2024ie
Agreement labeling IReL-T&F R&P
Has the agreement been disclosed and published? Yes
URL https://irel.ie/open-access/taylor-and-francis/
Agreement period 01/01/2024 – 12/31/2026
Consortia / Institution IReL
Country Ireland
SIZE

Approximate range of annual corresponding author publications

484
Comments on size/article output Based on 2022 reported output
COSTS

How do the costs of the agreement relate to previous subscription-only agreements with the publisher?

Agreement costs within the range of the previous spending level
FINANCIAL SHIFT

Transformative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?

Subscriptions partly converted to OA publishing fees
OA COVERAGE

Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?

Yes
Are fully open access journals covered by the agreement? No
OA LICENSE CC-BY variations allowed
ARTICLE TYPES
Original research articles
Review articles
Editorials
Full list of eligible article types: Article, Review, Research Article, Review Article, Report, Short Communication, Case Report, Note, Original Article, Guest Editorial
ACCESS COSTS

What is the approximate share of access related costs of the overall agreement?

5%-20%
ACCESS COVERAGE

Are all read relevant journals covered by the agreement?

No
PERPETUAL ACCESS RIGHTS Partly (e.g. to core journals only)
WORKFLOW ASSESSMENT Ok
OVERALL ASSESSMENT AND COMMENTS
Historically IReL has only licensed T&F’s SSH and Medical collections (not the Science collection). This continues into IReL’s 2021-2023 and 2024-2026 TAs, where we can we do not have read access to the Science hybrids, but they are eligible or OA publishing. This limits our ability to transition to OA with this publisher. We project that the currently agreement will cover only an estimated 60-70% of our output.
Request contact to the licensee contact@esac-initiative.org